Patent holdings for IPC class C07D 333/72

Total number of patents in this class: 84

10-year publication summary

5
5
9
5
4
4
8
5
3
0
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Zhejiang Jingxin Pharmaceutical Co., Ltd.
30
6
BASF SE
21292
4
Shanghai Jingxin Biomedical Co., Ltd.
23
4
Merck Patent GmbH
5725
3
Shangyu Jingxin Pharmaceutical Co., Ltd.
9
3
Duke University
3178
2
Purdue Research Foundation
3901
2
Chugai Seiyaku Kabushiki Kaisha
1412
2
Kyushu University, National University Corporation
1704
2
Nippon Kayaku Kabushiki Kaisha
1457
2
Ryvu Therapeutics SA
48
2
Shanghai Jingxin Biology & Pharmaceutical Co., Ltd.
7
2
Glaxo Group Limited
4376
1
Novartis AG
10300
1
Samsung Electronics Co., Ltd.
157039
1
LG Chem, Ltd.
17929
1
The Regents of the University of California
20690
1
Janssen Pharmaceutica N.V.
3177
1
Syngenta Participations AG
1538
1
Centre National de La Recherche Scientifique
10993
1
Other owners 42